The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Robitussin Chesty Cough 100mg/5ml Oral Solution

GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/153/001

Main Information

Trade NameRobitussin Chesty Cough 100mg/5ml Oral Solution
Active SubstancesGuaifenesin
Dosage FormOral solution
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/153/001

Group Information

ATC CodeR05CA Expectorants
R05CA03 guaifenesin


License statusAuthorised
Licence Issued01/04/1983
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back